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Antimicrobial Amyloids?
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School of Medicine, Semel Institute for
Neuroscience & Human Behavior,
University of California, Los Angeles,
CaliforniaThe molecular mechanisms by which
misfolded amyloid proteins cause dis-
ease would seem, at first, to have little
to do with the workings of the innate
immune system. However, the com-
panion work of Jang et al. (1) showing
the antimicrobial peptide protegrin
forms amyloid fibrils leads us to that
very conclusion. It would also seem
unlikely that the extended amorphous
deposits known as amyloid seen in
pathological specimens of human dis-
ease would have any similar biophysi-
cal properties to the relatively short
cytotoxic peptides responsible for host
defense. Yet, this, too, is the implica-
tion of recent research.
The role of amyloid proteins in dis-
ease has been at issue for over a century.
Rudolf Virchow first described the
Congo red-staining deposits seen in dis-
ease tissue and mistook them for carbo-
hydrates. It later became clear that the
main constituent of these deposits
was a single protein in a misfolded
state. The unique protein varies from
the beta-amyloid peptide (BAP) of
Alzheimer’s disease (AD) to the prion
protein (scrapie form PrPSc) of prion
diseases, such as mad cow and Creutz-
feldt-Jakob disease. Many years of
painstaking research were required to
dissect the true molecular nature of
amyloid deposits, showing that the
amyloid proteins were composed of
stacked beta sheets in the form of
extended fibrils. Their structure was
eventually solved through biophysicaldoi: 10.1016/j.bpj.2011.02.023
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and electron microscopy, but the role
of these deposits remained obscure.
For many years, the tombstone theory
held sway, which regarded the amyloid
deposits as a marker of some injurious
event that had happened in the past,
but was no longer an active process. In
the 1990s, the amyloid cascade hypoth-
esis (2), proposed that BAP played an
active role in the pathogenesis of AD.
Evidence for this theory included the
existence of inherited forms of the dis-
ease with mutations in or near BAP,
and the fact that patients with Trisomy
21 (Down’s Syndrome) carrying an
extra copy of the BAP gene experience
an early onset form of AD with cogni-
tive deficits appearing as early as the
third decade of life. A third line of
evidence demonstrated that the BAP
from humans could be inserted into
a transgenic mouse, resulting in an
Alzheimer’s-like disease characterized
by amyloid deposits and learning defi-
cits. More recently it has been shown
that most amyloid peptides do not
seem to be toxic in the monomeric or fi-
brillar state, but rather in a relatively
low aggregation state, usually referred
to as oligomers or protofibrils. These
smaller aggregates seem to possess
virtually all the cytotoxic activity of
amyloid peptides, and substantial evi-
dence suggests that channel formation
plays a key role in the cytotoxic effect.
Protegrins are a class of basic cyste-
ine-rich beta-sheet antimicrobial pep-
tides of ~18 residues which possess
potent cytotoxic activities against bac-
teria, fungi, and enveloped viruses.
They play an important role in the in-
nate immune system and are a critical
part of the armamentarium of neutro-
phils and macrophages. Protegrins kill
by breaching target membrane perme-
ability, although there remains some
controversy as to whether membrane
leakage is due to channel formation or
a carpet mechanism. Protegrins are a
mini version of the larger host defense
peptides known as defensins, of which
three major types have been described,
alpha, beta, and theta. All of these anti-microbial molecules possess a similar
size, basic amino acid content, several
disulfide bonds, and high content
of beta-sheet structure, and all these
structural factors appear to play a key
role in mediating cytotoxicity. In the
companion work, Jang et al. (1) report
that protegrin-1 forms fibrils with the
biophysical properties of amyloid.
This remarkable discovery confirms
and extends the notion that it is the
beta-sheet secondary structure that
predisposes it to fibril formation. It
provides further confirmation that the
beta-sheet is a uniquely suited protein
structure to allow aggregation of mono-
mers into oligomers and into larger ex-
tended structures. The data are striking
in that they show remarkable biophysi-
cal resemblances between the fibrils
formed by protegrins and fibrils formed
by more classic amyloid peptides. The
authors use atomic force microscopy,
Thioflavin T staining, and molecular
dynamic simulations to show that the
PG-1 fibrils grow relatively fast com-
pared to those of BAP fibrils and, curi-
ously, do not grow in the presence of
lipid bilayers. Previously, lipid bilayers
have been shownwith other amyloids to
inhibit fibril formation and to favor the
formation of small oligomers capable
of inserting into the bilayer.
If antimicrobials can form amyloid
fibrils, can amyloid peptides form anti-
microbials? The BAP itself possesses
antimicrobial activity under the appro-
priate conditions (3). These conditions,
it turns out, favor the formation of small
oligomers of beta-amyloid peptide of
the kind which would possess cytotoxic
and channel-forming function.
Some bacteria seem to produce am-
yloids for structural purposes and to
retard the growth of neighboring bacte-
ria (4). The companion work seems
to close the loop connecting protein
misfolding, beta-sheet structure, mem-
brane insertion, channel formation, and
cytotoxicity, as well as the alternate
pathway of monomer aggregation into
1598 Kaganextended amyloid fibrils which precip-
itate out of solution. Seen in this light,
some have commented that fibril for-
mation may, in fact, be protective, in
that fibrils are relatively nontoxic com-
pared to oligomers. Further research
will be required to demonstrate the
presence of oligomeric channels in dis-
ease tissue specimens and, ultimately,
therapeutic research avenues may ex-
plore the viability of molecules thatBiophysical Journal 100(7) 1597–1598prevent membrane insertion of oligo-
mers or block the toxic pores formed
by oligomers. The intriguing question
of whether amyloid peptides play
a host defense role in vivo remains to
be explored.REFERENCES
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